April 7, 1997
Media Contact: Gary Stephenson
Phone: (410) 955-5384
In a move to ensure that the increasing number of end stage kidney disease patients in the Baltimore area will receive the best and most timely dialysis care, Johns Hopkins Medicine has entered into a strategic affiliation with GAMBRO Healthcare, one of the nation's leading renal replacement therapy firms.
As part of the arrangement, GAMBRO has acquired the Hopkins outpatient kidney dialysis and home dialysis programs operated from a clinic located at 412 N. Bond St. in Baltimore, effective April 1, 1997. GAMBRO will own and operate the programs. Hopkins will retain ownership of the building in which the clinic is operated and will provide medical staffing for the Bond Street programs as well as the medical staffing for other clinics planned for development in the Baltimore area as part of the Hopkins/GAMBRO affiliation.
In order to maintain a continuity of care and patient clinical information, GAMBRO also has been engaged to provide acute services to inpatients of The Johns Hopkins Hospital.
While the number and location of new clinics have not been determined, Hopkins and GAMBRO officials say there is an urgent need for additional facilities throughout the Baltimore metropolitan area.
Paul Scheel Jr., M.D., the clinical director of nephrology, Department of Medicine, for The Johns Hopkins Hospital and School of Medicine, has been appointed medical director of the clinic. "GAMBRO Healthcare has distinguished itself from other dialysis providers by the quality and excellence of care it gives to dialysis patients," Scheel said. "The number of patients in the metropolitan area who need renal dialysis is increasing about 18 percent each year. We are very excited that we have united our efforts to provide the most advanced and dedicated care to the citizens of the Baltimore metropolitan area who suffer from renal diseases."
John D. Stobo, M.D., chairman and CEO of Johns Hopkins HealthCare, emphasized that the partnership will play an important role in augmenting Hopkins' integrated delivery system. "Our relationship with GAMBRO is a critical component of Hopkins' network to provide convenient, high-quality care to patients in the mid-Atlantic region who have end stage renal disease," he said. "The GAMBRO partnership also provides a seamless access point for additional medical services should they be required by renal dialysis patients."
Lawrence J. Centella, president of GAMBRO Healthcare Patient Services Inc., said, "We are extremely pleased to be affiliated with the Hopkins dialysis program. This agreement provides GAMBRO Healthcare with a team of highly qualified nephrologists, and more importantly, will ensure quality and greater accessibility for patients in the Baltimore area."
Mats Wahlstr–m, president of GAMBRO Healthcare Inc., commented, "As we continue to expand our network of clinics, strategic associations with prestigious medical institutions, like Hopkins, have enabled us to grow while maintaining the high standards that are an essential part of improving the quality of life for our patients."
GAMBRO Healthcare is headquartered in Nashville, Tenn. Its centers are associated with several academic institutions, such as Duke, Harvard, Emory, the Medical College of Virginia and Yale.